Free Trial

BioNTech (BNTX) News Today

BioNTech logo
$101.72 +3.92 (+4.01%)
As of 05/20/2025 04:00 PM Eastern

BNTX Latest News

Moderna stock soars on FDA booster trial plans
BioNTech SE stock logo
Tema Etfs LLC Acquires New Shares in BioNTech SE (NASDAQ:BNTX)
Tema Etfs LLC acquired a new stake in BioNTech SE (NASDAQ:BNTX - Free Report) during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 4,500 shares of the company's stock, valued at approximately $513,000.
BioNTech SE stock logo
Shell Asset Management Co. Makes New $2.22 Million Investment in BioNTech SE (NASDAQ:BNTX)
Shell Asset Management Co. purchased a new position in BioNTech SE (NASDAQ:BNTX - Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund purchased 19,440 shares of the company's stock, valued at approximately $2,215,000. A number of ot
BioNTech SE stock logo
Raiffeisen Bank International AG Purchases New Position in BioNTech SE (NASDAQ:BNTX)
Raiffeisen Bank International AG purchased a new stake in shares of BioNTech SE (NASDAQ:BNTX - Free Report) in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 10,000 shares of the company's stock, valued at approximately
BioNTech SE stock logo
OMERS ADMINISTRATION Corp Purchases New Holdings in BioNTech SE (NASDAQ:BNTX)
OMERS ADMINISTRATION Corp acquired a new stake in BioNTech SE (NASDAQ:BNTX - Free Report) during the 4th quarter, according to its most recent filing with the SEC. The institutional investor acquired 8,900 shares of the company's stock, valued at approximately $1,014,000. Other large investors als
BioNTech SE stock logo
Jefferies Financial Group Inc. Acquires New Shares in BioNTech SE (NASDAQ:BNTX)
Jefferies Financial Group Inc. acquired a new stake in BioNTech SE (NASDAQ:BNTX - Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 5,000 shares of the company's stock, valued at approximately $570,000. Seve
Research Analysts Offer Predictions for BioNTech Q2 Earnings
BioNTech SE stock logo
Deutsche Bank AG Raises Stock Holdings in BioNTech SE (NASDAQ:BNTX)
Deutsche Bank AG raised its holdings in BioNTech SE (NASDAQ:BNTX - Free Report) by 2.3% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 304,500 shares of the company's stock after purchasi
5BNTX : Where BioNTech Stands With Analysts
BioNTech SE stock logo
Integral Health Asset Management LLC Boosts Holdings in BioNTech SE (NASDAQ:BNTX)
Integral Health Asset Management LLC boosted its position in shares of BioNTech SE (NASDAQ:BNTX - Free Report) by 100.0% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 100,000 shares of the company's stock after buying an ad
What’s the Bull Case for US Equities?
BioNTech SE stock logo
Crestline Management LP Takes $943,000 Position in BioNTech SE (NASDAQ:BNTX)
Crestline Management LP purchased a new stake in shares of BioNTech SE (NASDAQ:BNTX - Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 8,272 shares of the company's stock, valued at appro
BioNTech SE stock logo
DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main Increases Position in BioNTech SE (NASDAQ:BNTX)
DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main lifted its position in shares of BioNTech SE (NASDAQ:BNTX - Free Report) by 632.6% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 501,897 shares of the company's
BioNTech SE stock logo
Fred Alger Management LLC Sells 35,467 Shares of BioNTech SE (NASDAQ:BNTX)
Fred Alger Management LLC lessened its position in shares of BioNTech SE (NASDAQ:BNTX - Free Report) by 7.1% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 465,377 shares of the company's stock after selling 35,467 sh
BioNTech SE stock logo
Raymond James Financial Inc. Buys Shares of 5,122 BioNTech SE (NASDAQ:BNTX)
Raymond James Financial Inc. purchased a new position in shares of BioNTech SE (NASDAQ:BNTX - Free Report) in the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor purchased 5,122 shares of the company's stock, valued at approximately $
BioNTech SE stock logo
Capstone Investment Advisors LLC Has $315,000 Position in BioNTech SE (NASDAQ:BNTX)
Capstone Investment Advisors LLC cut its holdings in shares of BioNTech SE (NASDAQ:BNTX - Free Report) by 57.7% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 2,767 shares of the company's stock after
BioNTech SE stock logo
BNP Paribas Financial Markets Takes Position in BioNTech SE (NASDAQ:BNTX)
BNP Paribas Financial Markets bought a new position in shares of BioNTech SE (NASDAQ:BNTX - Free Report) in the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund bought 614,297 shares of the company's stock, valued at approximately $69,999,000. BNP Paribas Financial M
BioNTech SE stock logo
Morgan Stanley Issues Pessimistic Forecast for BioNTech (NASDAQ:BNTX) Stock Price
Morgan Stanley reduced their target price on shares of BioNTech from $140.00 to $132.00 and set an "overweight" rating for the company in a report on Tuesday.
BioNTech SE stock logo
Braidwell LP Raises Stake in BioNTech SE (NASDAQ:BNTX)
Braidwell LP grew its position in BioNTech SE (NASDAQ:BNTX - Free Report) by 25.1% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 309,865 shares of the company's stock after purchasing an additiona
BioNTech SE stock logo
BioNTech (NASDAQ:BNTX) Issues Quarterly Earnings Results
BioNTech (NASDAQ:BNTX - Get Free Report) posted its quarterly earnings data on Monday. The company reported ($1.82) EPS for the quarter, topping the consensus estimate of ($2.68) by $0.86. BioNTech had a negative return on equity of 2.35% and a negative net margin of 15.16%.
BioNTech SE stock logo
Baker BROS. Advisors LP Invests $5.13 Million in BioNTech SE (NASDAQ:BNTX)
Baker BROS. Advisors LP purchased a new stake in shares of BioNTech SE (NASDAQ:BNTX - Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund purchased 45,031 shares of the company's stock, valued at approximately $5,131,000. A number of oth
BioNTech SE stock logo
Voya Investment Management LLC Purchases 3,520 Shares of BioNTech SE (NASDAQ:BNTX)
Voya Investment Management LLC lifted its holdings in BioNTech SE (NASDAQ:BNTX - Free Report) by 14.5% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 27,870 shares of the company's stock after purchasing an additional 3,
Get BioNTech News Delivered to You Automatically

Sign up to receive the latest news and ratings for BNTX and its competitors with MarketBeat's FREE daily newsletter.

BNTX Media Mentions By Week

BNTX Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

BNTX
News Sentiment

1.19

0.65

Average
Medical
News Sentiment

BNTX News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

BNTX Articles
This Week

19

12

BNTX Articles
Average Week

Get BioNTech News Delivered to You Automatically

Sign up to receive the latest news and ratings for BNTX and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:BNTX) was last updated on 5/21/2025 by MarketBeat.com Staff
From Our Partners